Integration of nano and biotechnology for beta cell and islet transplantation in type 1 diabetes treatment
Regenerative medicine using human or porcine b cells or islets has an excellent potential to become a clinically relevant method for the treatment of type 1 diabetes. High resolution imaging of the function and faith of transplanted porcine pancreatic islets and human stem cell derived beta cells in large animals and patients for testing advanced therapy medicinal products (ATMPs) is a currently unmet need for pre clinical/clinical trials. The iNanoBIT EU H2020 project is developing novel highly sensitive nanotechnology based imaging approaches allowing for monitoring of survival, engraftment, proliferation, function and whole body distribution of the cellular transplants in a porcine diabetes model with excellent translational potential to humans. We develop and validate the application of single photon emission computed tomography (SPECT) and optoacoustic imaging technologies in a transgenic insulin deficient pig model to observe transplanted porcine xeno islets and in vitro differentiated human beta cells. We are progressing in generating new transgenic reporter pigs and human induced pluripotent cell (iPSC) lines for optoacoustic imaging and testing them in transplantable bioartificial islet devices. Novel multifunctional nanoparticles have been generated and are being tested for nuclear imaging of islets and beta cells using a new, high resolution SPECT imaging device. Overall, the combined multidisciplinary expertise of the project partners allows progress towards creating much needed technological toolboxes for the xenotransplantation and ATMP field, and thus reinforces the European healthcare supply chain for regenerative medicinal products.
Cell proliferation